Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Long-Term Deferred Tax (2016 - 2025)

Icu Medical (ICUI) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $24.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Deferred Tax changed N/A year-over-year to $24.0 million, compared with a TTM value of $24.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $24.2 million, down 35.08% over the prior year.
  • Long-Term Deferred Tax was $24.0 million for Q3 2025 at Icu Medical, up from $23.1 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $77.6 million in Q1 2022 and bottomed at $15.5 million in Q3 2022.
  • Average Long-Term Deferred Tax over 5 years is $34.3 million, with a median of $31.3 million recorded in 2021.
  • The sharpest move saw Long-Term Deferred Tax skyrocketed 166.41% in 2022, then crashed 59.43% in 2023.
  • Year by year, Long-Term Deferred Tax stood at $42.6 million in 2021, then fell by 26.14% to $31.5 million in 2022, then increased by 18.52% to $37.3 million in 2023, then crashed by 35.08% to $24.2 million in 2024, then decreased by 0.97% to $24.0 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for ICUI at $24.0 million in Q3 2025, $23.1 million in Q2 2025, and $24.2 million in Q4 2024.